Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Boyu Capital

Founders Mary Ma

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 70
Average round size
info
The average size of a deal this fund participated in
$344M
Portfolio companies 58
Rounds per year 5.00
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.13
Exits 12
Key employees 4
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • E-Commerce
  • Pharmaceutical
  • Biopharma
Summary

In 2010 was created Boyu Capital, which is appeared as VC. The main department of described VC is located in the Beijing. The venture was found in Asia in China.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Boyu Capital, startups are often financed by Tencent Holdings, Morningside Venture Capital, Matrix Partners. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, 6 Dimensions Capital, YF Capital (Yunfeng Capital). In the next rounds fund is usually obtained by Temasek Holdings, 6 Dimensions Capital, blisce/.

The typical startup value when the investment from Boyu Capital is more than 1 billion dollars. Comparing to the other companies, this Boyu Capital performs on 13 percentage points less the average number of lead investments. The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of more than 100 millions dollars. Considering the real fund results, this VC is 12 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. The fund is constantly included in 2-6 deals per year.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Diagnostics, Financial Services. Among the most popular portfolio startups of the fund, we may highlight Alibaba, iQiyi, LY.com. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

This organization was formed by Mary Ma. The overall number of key employees were 4.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Boyu Capital:
Typical Co-investors
Boyu Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Boyu Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Positive Sequence Biology

Biopharma
Biotechnology
Genetics
$15M08 Aug 2024 Shanghai, Shanghai, China

Tai Hydrogen Energy

Clean Energy
GreenTech
$23M10 Jan 2024 Shanghai, Shanghai, China

Doujin Culture

E-Commerce
Information Services
Service Industry
$2M12 Sep 2023 Hangzhou, Zhejiang, China

Farizon Auto

Autonomous Vehicles
Clean Energy
Electric Vehicle
$600M07 Jul 2023 Hangzhou, Zhejiang, China

Tianbing Technology

Aerospace
Travel
$15M06 Jul 2023 Dongcheng District, Beijing, China

Evat Master

E-Commerce
Productivity Tools
SaaS
$46M01 Jun 2022 Shenzhen, Guangdong, China

ArriVent Biopharma

Biotechnology
Pharmaceutical
$69M15 Feb 2022 Pennsylvania Furnace, Pennsylvania, United States

Positive Sequence Biology

Biopharma
Biotechnology
Genetics
$46M08 Nov 2021 Shanghai, Shanghai, China

Edge Medical Robotics

Health Care
$200M05 Nov 2021 Futian District, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Boyu Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 70
Average round size 344M
Rounds per year 5.00
Peak activity year 2021
Lead investments 11
Follow on index 0.13
Exits 12
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Positive Sequence Biology

Biopharma
Biotechnology
Genetics
$15M08 Aug 2024 Shanghai, Shanghai, China

Tai Hydrogen Energy

Clean Energy
GreenTech
$23M10 Jan 2024 Shanghai, Shanghai, China

Doujin Culture

E-Commerce
Information Services
Service Industry
$2M12 Sep 2023 Hangzhou, Zhejiang, China

Farizon Auto

Autonomous Vehicles
Clean Energy
Electric Vehicle
$600M07 Jul 2023 Hangzhou, Zhejiang, China

Tianbing Technology

Aerospace
Travel
$15M06 Jul 2023 Dongcheng District, Beijing, China

Evat Master

E-Commerce
Productivity Tools
SaaS
$46M01 Jun 2022 Shenzhen, Guangdong, China

ArriVent Biopharma

Biotechnology
Pharmaceutical
$69M15 Feb 2022 Pennsylvania Furnace, Pennsylvania, United States

Positive Sequence Biology

Biopharma
Biotechnology
Genetics
$46M08 Nov 2021 Shanghai, Shanghai, China

Edge Medical Robotics

Health Care
$200M05 Nov 2021 Futian District, Guangdong Province, China
Crunchbase icon

Content report

The following text will be sent to our editors: